Loading…
Phaarmasia (BSE 523620)₹79.55−2.99%Pharmaceuticals
At the end of the Jun 2026 quarter, Phaarmasia's shareholders were: promoters 73.46%, DIIs 0.05%, public 26.49%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 20,277 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% | 73.46% |
| DIIs | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% | 26.49% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 20,713 | 20,679 | 20,673 | 20,633 | 20,587 | 20,603 | 20,611 | 20,503 | 20,488 | 20,395 | 20,292 | 20,277 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Maneesh Pharmaceuticals Limited | Promoter | 44.27% | 0.00 |
| Svizera Labs Pvt Ltd | Promoter | 29.32% | 0.00 |
| Shubhada Godambe Atul | Public | 1.75% | 0.00 |
| Madhavi Pradeep Save | Public | 1.72% | 0.00 |
| Kalpana Patankar | Public | 1.64% | 0.00 |
| Amruta Nishant Kalsekar | Public | 1.50% | 0.00 |
Promoters held 73.46% of Phaarmasia at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held no reported stake and domestic institutions (DIIs) held 0.05% (unchanged at 0.05% a quarter earlier).
No. The Jun 2026 filing shows no pledged promoter shares.
Phaarmasia had 20,277 shareholders at the end of the Jun 2026 quarter, against 20,503 a year earlier.
Shubhada Godambe Atul (Public) held 1.75% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.